title: The management of eosinophilic gastroenteritis.
abstract: Eosinophilic gastroenteritis (EG) is a rare disorder characterized by eosinophilic infiltration of the gastrointestinal tract. No medication at present is approved by the Food and drug administration of United States for the treatment of EG. The rarity of the disease limits our experience with the different management options. It also limits the ability to conduct randomized controlled trials that could clearly delineate the efficacy of new therapeutic agents. This review assesses the various management options that have been tried on patients with EG.
authors.affiliation: Department of Medicine, Westchester Medical Center, New York Medical College , Valhalla, NY , USA.
authors.forename: Nancy
authors.initials: N
authors.lastname: Gupta
authors.forename: Arun
authors.initials: A
authors.lastname: Aggarwal
authors.forename: Rahul
authors.initials: R
authors.lastname: Gupta
authors.forename: Sachin
authors.initials: S
authors.lastname: Sule
authors.forename: David C
authors.initials: DC
authors.lastname: Wolf
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004035:Diet Therapy / Q000379:methods; D019468:Disease Management; D004751:Enteritis / Q000628:therapy*; D004802:Eosinophilia / Q000628:therapy*; D005756:Gastritis / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents
keywords: Eosinophilic gastroenteritis; elimination diet; immunomodulators